Qulab Inc.
Site unreachableAI-nativeMolecular Design, Automated
What it does
Qulab Inc. is a pioneering company in the fields of energy, health, and new materials & packaging, specializing in molecular design automation for small molecules used in therapeutics, chemicals, and energy applications. At the forefront of innovation, Qulab has introduced QULEAP, the world's first fully-integrated AI platform for de novo small molecule design. This cutting-edge technology revolutionizes the process of designing small molecules, offering unprecedented efficiency and accuracy in creating compounds for various applications. By automating the design process, Qulab is driving advancements in pharmaceuticals, chemicals, and energy sectors, leading the way towards more efficient and effective solutions in molecular design.
Next to it in Healthcare and bio · AI molecular design automation
- SyntheticGestalt株式会社Plug and Play
SyntheticGestalt develops machine learning models for drug discovery and software for facilitating and automating research.
- CAMSENS GmbHPlug and Play
CAMSENS GmbH helps veterinarians and laboratories double the speed of pathogen detection using automation and AI.
- Care AdvisorsPlug and Play
CareAdvisors builds technology platforms that enable the elimination of disparities and inequity in healthcare.
- CliniservePlug and Play
Cliniserve changes the way nurses are allocated in hospitals while helping nurses with their daily routines.
- エムスリーデジカル株式会社Plug and Play
M3 DigiKar is a software tool for electronic medical records with information to get medical services and help to reduce medical expenses.
- GlidianPlug and Play
Simplifying prior authorizations
- KanataPlug and Play
Kanata building & operating hospital information systems like electronic medical records for hospitals, Parsing R&D, etc.
- PharmesolPlug and Play
Pharmesol is a clinical services platform that automates follow-up care for medications.